Immunodeficiency secondary to biologics

Affiliations

¹ Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada.
² Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada; Department of Microbiology, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada. Electronic address: elie.haddad@umontreal.ca.

Editorial

Roxane Labrosse et al. J Allergy Clin Immunol. 2023 Mar.

. 2023 Mar;151(3):686-690.

doi: 10.1016/j.jaci.2023.01.012. Epub 2023 Jan 24.

¹ Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada.
² Department of Pediatrics, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada; Department of Microbiology, Immunology and Infectious Diseases, CHU Sainte-Justine, University of Montréal, Montréal, Québec, Canada. Electronic address: elie.haddad@umontreal.ca.

No abstract available

Keywords: Secondary immunodeficiency; acquired immunodeficiency; biologics; immunomodulatory medications; immunosuppressive medications.

Publication types